J&J gives pioneering stem cell biotech its first Big Pharma deal, partnering on iPSC CAR-T and CAR-NK
Late last summer, one of the earliest stem cell therapy companies got two government decisions in the span of three weeks: The USPTO granted them …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
